A quarter of adults worldwide have non-alcoholic fatty liver disease, a condition where excess fat is stored in the liver and is closely linked to obesity and diabetes.
The consumption of excess sugar and carbohydrates causes the liver to convert them into fat in a process called hepatic De Novo Lipogenesis or DNL.
Japanese and European scientists were the first to report a strange four-fold increase in heart disease in these patients compared to those of the same age and sex who had normal livers.
According to the study, the benefits were seen regardless of sex, severity of hepatitis, or type of hepatitis virus (B or C).
Non-alcoholic fatty liver disease is a significant global health problem that is expected to worsen.
The findings show promise for these bioactive compounds, when consumed as part of the diet, as a strategy for preventing obesity-related chronic illnesses.
Meanwhile, the researchers found that equally high levels of glucose in the diet actually improved the fat-burning function of the liver.
Liver is an organ which tirelessly works hard to maintain the health and balance of the human body.
One of the first things that will be put in place is a trans fat laboratory where food samples can be tested for their trans fat density.
Besides medication, the patients should also follow a healthy diet, regulate their body weight and give up alcohol for speedy recovery from fatty liver.